NYSEMKT: ARMP
Armata Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for ARMP

Based on 1 analyst offering 12 month price targets for Armata Pharmaceuticals Inc

Min Forecast
$7.00+469.11%
Avg Forecast
$7.00+469.11%
Max Forecast
$7.00+469.11%

Should I buy or sell ARMP stock?

Based on 1 analyst offering ratings for Armata Pharmaceuticals Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ARMP stock forecasts and price targets.

ARMP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-12-19

1 of 1

ARMP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ARMP$1.23$7.00+469.11%Buy
SKYE$1.44$14.50+910.45%Buy
PRLD$0.81$4.50+455.56%Buy
MRSN$0.36N/AN/A
ONCY$0.56$4.33+672.37%Strong Buy

Armata Pharmaceuticals Stock Forecast FAQ

Is Armata Pharmaceuticals Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSEMKT: ARMP) stock is to Buy ARMP stock.

Out of 1 analyst, 0 (0%) are recommending ARMP as a Strong Buy, 1 (100%) are recommending ARMP as a Buy, 0 (0%) are recommending ARMP as a Hold, 0 (0%) are recommending ARMP as a Sell, and 0 (0%) are recommending ARMP as a Strong Sell.

If you're new to stock investing, here's how to buy Armata Pharmaceuticals stock.

What is ARMP's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ARMP price target, the average ARMP price target is $7.00, with the highest ARMP stock price forecast at $7.00 and the lowest ARMP stock price forecast at $7.00.

The Wall Street analyst predicted that Armata Pharmaceuticals's share price could reach $7.00 by Dec 19, 2025. The average Armata Pharmaceuticals stock price prediction forecasts a potential upside of 469.11% from the current ARMP share price of $1.23.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.